TITLE:
Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

CONDITION:
Hypercholesterolemia

INTERVENTION:
MK0653, ezetimibe

SUMMARY:

      The purpose of this study is to assess the cholesterol lowering safety and effectiveness of
      two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high
      triglycerides).
    

DETAILED DESCRIPTION:

      The duration of treatment is 48 weeks.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 75 Years
Criteria:

        Inclusion Criteria:

          -  High cholesterol and high triglycerides

        Exclusion Criteria:

          -  Patient has a condition which, in the opinion of the investigator, might pose a risk
             to the patient, interfere with participation in the study, or does not meet the
             additional criteria as required by the study
      
